Development of a Developmental Prognostic Tool for the Premature Child Based on Automated Spontaneous Motor Analysis
NCT ID: NCT04770844
Last Updated: 2024-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
129 participants
OBSERVATIONAL
2021-03-23
2023-06-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Physical Therapy Intervention in Preterm Infants
NCT03313427
Psychomotor Therapy for Very Premature Infants
NCT03093337
Interdisciplinary Hospital-home Intervention on Motor Development in Premature Children
NCT04563364
Long-term Neurodevelopmental Disorders of Prematurely Born Children and Parental Experience
NCT04607109
Neurodevelopmental Outcomes of Preterm and Term Children
NCT02309697
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
premature child
300 premature child will be included. They will have three acquisitions during hospitalization.
Acquisitions
Three acquisitions of 1 hours during hospitalization will be realized:
* a few days after hospitalization,
* in the middle of the hospitalization,
* a few days before hospital discharge. The child will be lying on his back in a heated cradle and filmed with a specific camera. The signal will be obtained by 2k ZED 2 stereo camera in order to obtain a three-dimensional location of the child
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acquisitions
Three acquisitions of 1 hours during hospitalization will be realized:
* a few days after hospitalization,
* in the middle of the hospitalization,
* a few days before hospital discharge. The child will be lying on his back in a heated cradle and filmed with a specific camera. The signal will be obtained by 2k ZED 2 stereo camera in order to obtain a three-dimensional location of the child
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalization in the Neonatal Department of the Saint-Étienne University Hospital
* Patient affiliated or entitled to a social security scheme;
* Authorization to shoot the holders of parental authority;
* Consent to participate in the study by the holders of parental authority
Exclusion Criteria
* Difficulty of thermal regulation contraindicating the use of a heating cradle;
* Refusal of authorization to shoot by holders of parental authority;
* Refusal of participation in the study of holders of parental authority.
1 Day
3 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jean Monnet University
OTHER
Laboratoire EA SNA=EPIS 4607.
UNKNOWN
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ANTOINE GIRAUD, MD
Role: PRINCIPAL_INVESTIGATOR
CHU ST ETIENNE FRANCE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu de St Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-A03335-34
Identifier Type: OTHER
Identifier Source: secondary_id
20CH234
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.